Joan Clària

The VISTA Variables in the Vía Láctea extended (VVVX) ESO public survey: Completion of the observations and legacy

Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure

Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF

Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

Albumin in decompensated cirrhosis: new concepts and perspectives

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF

Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis

Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis

Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough

Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure

Prostaglandin E2 Exerts Multiple Regulatory Actions on Human Obese Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis

Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat